# Michael Marks

> Michael Marks is a Series A investor at Celesta Capital backing Internet and Software. See 39 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Celesta Capital](https://shizune.co/investors/profile/wrvi-capital)
- Location: Menlo Park, United States
- Total investments: 39
- Last investment: Nov 2024
- Lead investor: 56%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/michael-e-marks-0380a9b

Michael Marks is a Series A investor at Celesta Capital in Menlo Park focused on Internet and Software. Michael E Marks is the Founding Managing Partner at Celesta Capital. Prior to that, he was the CEO and founder of Katerra. He was also the founding partner of Riverwood Capital, a Menlo Park-based private equity firm. Prior to establishing Riverwood, he was a partner and senior advisor at Kohlberg Kravis Roberts & Co. in 2006 and 2007.Priorto KKR, Michael spent 13 years as CEO and then chairman of Flextronics International Ltd., building it into one of the largest technology companies in the world.He is a director of The Melt, Enjoy, H20.ai, and Berkeley Lights.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $850k–$13M |
| Series A | $3M–$16M |
| Series B | $1.7M–$27M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Internet | 5 | 13% |
| Software | 5 | 13% |
| E-Commerce | 5 | 13% |
| Analytics | 4 | 10% |
| Artificial Intelligence | 4 | 10% |

74 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 10 | 26% |
| Seed | 8 | 21% |
| Series B | 3 | 8% |
| Series C | 3 | 8% |
| Convertible Note | 2 | 5% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 19 | 49% |
| India | 2 | 5% |
| Japan | 1 | 3% |
| Brazil | 1 | 3% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| OneCell Diagnostics | OneCell Diagnostics is a Precision Oncology Liquid Biopsy Diagnostics Company. | $16M | Series A | Nov 21, 2024 |  |
| OneCell Diagnostics | OneCell Diagnostics is a Precision Oncology Liquid Biopsy Diagnostics Company. | $16M | Series A | Nov 21, 2024 |  |
| Finicast | Finicast provides business financial planning and analysis software. Finicast software assists FP&A teams, financial analysts, and businesses in developing detailed and scalable financial forecasts, as well as financial management and tracking solutions. | $12.8M | Seed | Jul 27, 2023 |  |
| Finicast | Finicast provides business financial planning and analysis software. Finicast software assists FP&A teams, financial analysts, and businesses in developing detailed and scalable financial forecasts, as well as financial management and tracking solutions. | $12.8M | Seed | Jul 27, 2023 |  |
| Very Good Ventures | Very Good Ventures is an design and development firm dedicated to enabling software excellence on any platform. We are the world leaders in Flutter development. We collaborate with global scale enterprises and emerging startups to create, build, and scale successful apps. We unite technology, empower teams, and amplify experiences. | $3.4M | Series A | Jul 26, 2023 |  |
| Very Good Ventures | Very Good Ventures is an design and development firm dedicated to enabling software excellence on any platform. We are the world leaders in Flutter development. We collaborate with global scale enterprises and emerging startups to create, build, and scale successful apps. We unite technology, empower teams, and amplify experiences. | $3.4M | Series A | Jul 26, 2023 |  |
| Prellis Biologics | Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.The companywas founded in 2016 and is based in San Francisco, California. | $35M | Series C | Aug 10, 2022 |  |
| Prellis Biologics | Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics'​ technology leverages massive gains in print speed and resolution to break the microvasculature barrier.The companywas founded in 2016 and is based in San Francisco, California. | $35M | Series C | Aug 10, 2022 |  |
| Very Good Ventures | Very Good Ventures is an design and development firm dedicated to enabling software excellence on any platform. We are the world leaders in Flutter development. We collaborate with global scale enterprises and emerging startups to create, build, and scale successful apps. We unite technology, empower teams, and amplify experiences. | $3M | Series A | May 17, 2022 |  |
| Very Good Ventures | Very Good Ventures is an design and development firm dedicated to enabling software excellence on any platform. We are the world leaders in Flutter development. We collaborate with global scale enterprises and emerging startups to create, build, and scale successful apps. We unite technology, empower teams, and amplify experiences. | $3M | Series A | May 17, 2022 |  |

10 of 39 investments shown.

## Co-investors
- [Celesta Capital](https://shizune.co/investors/profile/celesta-capital) — VC Fund, 14 deals together
- [Celesta Capital](https://shizune.co/investors/profile/wrvi-capital) — VC Fund, 11 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 6 deals together
- [Black Diamond Ventures](https://shizune.co/investors/profile/black-diamond-ventures) — VC Fund, 4 deals together
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 4 deals together
- [Lucas Venture Group](https://shizune.co/investors/profile/lucas-venture-group) — VC Fund, 4 deals together

## About Celesta Capital

VC Fund · San Francisco, United States

Celesta Capital is a venture capital firm that invests in entrepreneurs and disruptive technology companies. Their management team and investment professionals leverage over 400 years of accumulated investment and operational experience and bring to their portfolio companies a deep and unmatched network of value-added strategic relationships.Celesta Capital invests globally and has offices in California, Israel, India, and China

5 contacts available at Celesta Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Michael Marks | Founding Managing Partner | https://shizune.co/investors/profile/michael-e-marks |
| Anand Chandrasekaran | President, Co-founder, and Managing Partner | https://shizune.co/investors/profile/anand-chandrasekaran |
| Andrew Kau | Partner | https://shizune.co/investors/profile/andrew-kau |
| Arun Kumar | Managing Partner | https://shizune.co/investors/profile/arun-kumar-8 |
| Ganapathy Subramaniam | Partner | https://shizune.co/investors/profile/ganapathy-subramaniam-2 |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Climate Angel Investors in United States](https://shizune.co/investors/climate-angel-investors-united-states)
- [Retail Angel Investors](https://shizune.co/investors/retail-angel-investors)
- [Manufacturing Angel Investors](https://shizune.co/investors/manufacturing-angel-investors)
- [Retail Angel Investors in United States](https://shizune.co/investors/retail-angel-investors-united-states)
- [Manufacturing Angel Investors in United States](https://shizune.co/investors/manufacturing-angel-investors-united-states)
- [Big Data Angel Investors in India](https://shizune.co/investors/big-data-angel-investors-india)

## FAQ

### What does Michael Marks invest in?

Michael Marks invests primarily in Internet, Software and E-Commerce startups, most often at Series A and Seed stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Michael Marks's check size?

Michael Marks typically joins rounds of $850k–$13M at Seed, $3M–$16M at Series A and $1.7M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Michael Marks participates in.

### When did Michael Marks last invest?

The most recent investment recorded for Michael Marks closed in Nov 2024. Shizune tracks 39 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co